Both in Pharmaceuticals
Lite Strategy vs Veru
Over the past year LITS returned −45.9% and VERU returned −30.8%; their daily moves had a correlation of 0.16.
LITS −45.9% VERU −30.8%Growth of $1, one year, split-adjusted
| Metric | LITS | VERU |
|---|---|---|
| Price | $1.38 | $2.56 |
| Market cap | $41.8M | $43.6M |
| Today | +1.10% | +1.39% |
| 1 month | +40.2% | −2.5% |
| 6 months | +32.2% | +20.2% |
| Year to date | +4.2% | +19.6% |
| 1 year | −46.3% | −31.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.7M | $25.8M |
| Dividend yield | — | — |
| Volatility (60d) | 74.0% | 62.2% |
| Short % of float | 0.3% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).